Olin (NYSE:OLN - Get Free Report) had its target price decreased by investment analysts at KeyCorp from $34.00 to $32.00 in a research note issued on Monday,Benzinga reports. The firm currently has an "overweight" rating on the specialty chemicals company's stock. KeyCorp's target price indicates a potential upside of 48.37% from the stock's previous close.
Several other analysts also recently commented on OLN. UBS Group raised their target price on Olin from $22.00 to $23.00 and gave the company a "neutral" rating in a research note on Wednesday, July 9th. Royal Bank Of Canada dropped their price objective on shares of Olin from $25.00 to $23.00 and set a "sector perform" rating for the company in a report on Thursday, July 3rd. Barclays lowered their price objective on shares of Olin from $28.00 to $24.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 28th. JPMorgan Chase & Co. dropped their price target on Olin from $28.00 to $20.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 6th. Finally, The Goldman Sachs Group decreased their target price on shares of Olin from $33.00 to $25.00 and set a "neutral" rating for the company in a research note on Tuesday, May 6th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $27.27.
Check Out Our Latest Report on OLN
Olin Stock Down 4.7%
NYSE:OLN opened at $21.57 on Monday. The stock has a market cap of $2.48 billion, a price-to-earnings ratio of 42.26 and a beta of 1.52. The stock has a 50-day moving average price of $20.68 and a two-hundred day moving average price of $24.48. Olin has a 1 year low of $17.66 and a 1 year high of $50.75. The company has a current ratio of 1.56, a quick ratio of 0.96 and a debt-to-equity ratio of 1.48.
Olin (NYSE:OLN - Get Free Report) last posted its earnings results on Thursday, May 1st. The specialty chemicals company reported $0.04 EPS for the quarter, beating the consensus estimate of ($0.10) by $0.14. Olin had a return on equity of 3.13% and a net margin of 0.94%. The company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the business earned $0.40 earnings per share. The firm's revenue for the quarter was up 1.2% on a year-over-year basis. As a group, equities analysts expect that Olin will post 1.38 earnings per share for the current year.
Hedge Funds Weigh In On Olin
Large investors have recently bought and sold shares of the business. Fuller & Thaler Asset Management Inc. lifted its holdings in Olin by 40.5% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 6,384,744 shares of the specialty chemicals company's stock valued at $154,766,000 after acquiring an additional 1,840,900 shares during the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Olin by 5,746.2% in the fourth quarter. Thrivent Financial for Lutherans now owns 1,613,796 shares of the specialty chemicals company's stock valued at $54,546,000 after acquiring an additional 1,586,192 shares in the last quarter. Norges Bank acquired a new stake in shares of Olin in the fourth quarter valued at $47,887,000. Hotchkis & Wiley Capital Management LLC raised its stake in shares of Olin by 11.5% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 12,191,163 shares of the specialty chemicals company's stock valued at $295,514,000 after acquiring an additional 1,259,795 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Olin by 14.3% in the first quarter. Dimensional Fund Advisors LP now owns 4,546,352 shares of the specialty chemicals company's stock valued at $110,204,000 after acquiring an additional 569,483 shares in the last quarter. Institutional investors and hedge funds own 88.67% of the company's stock.
About Olin
(
Get Free Report)
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Olin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olin wasn't on the list.
While Olin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.